NCT02839746View on ClinicalTrials.gov

Treatment Convenience in Patients Treated With Dabigatran for Stroke Prophylaxis in Atrial Fibrillation (SPAF)

CompletedOBSERVATIONAL
Enrollment

671

Participants

Timeline

Start Date

June 13, 2016

Primary Completion Date

October 10, 2018

Study Completion Date

October 10, 2018

Conditions
Atrial Fibrillation
Trial Locations (1)

Unknown

Multiple Locations

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02839746 - Treatment Convenience in Patients Treated With Dabigatran for Stroke Prophylaxis in Atrial Fibrillation (SPAF) | Biotech Hunter | Biotech Hunter